Sabz Biomedicals
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (NCT04653493) | Sabz Biomedicals | 2021-08-01 |
| Autologous Killer Cell Therapy in Colon Cancer Patients (NCT03329664) | Sabz Biomedicals | 2020-02-09 |
Track Sabz Biomedicals automatically
Every clearance here is in the API, with alerts when new ones post.